Core Scientific, Inc. Common Stock (CORZ) Financials

Key financial figures for Core Scientific, Inc. Common Stock (Q3 2026).

Colocation revenue rose to $215.4M, up 57.6% from Q2, as billing capacity reached 485 MW, while a $1.03B warrant fair-value gain lifted GAAP net income to $1.18B. Total revenue was $232.9M, up from $164.2M in Q2 2026 (+41.8%, calculated) and $81.1M in Q3 2025. Colocation revenue was $215.4M against $136.7M in Q2 and $15.0M a year earlier, driven by delivery of billing megawatts. Billing capacity reached 485 MW at September 30, 2026 from 395 MW at June 30. The 10-Q shows 1,120 MW of leased customer power capacity, up from 590 MW at June 30, after the July 2026 AMD and Neocloud leases. Figures are for Q3 2026, as Core Scientific Inc. reported them.

Revenue
$233M
Net Income
$1.2B
EPS
$3.42
Total Assets
$5.9B
Operating Cash Flow
$65M

Recent quarters

PeriodRevenueNet IncomeEPSOperating MarginFree Cash Flow
Q3 FY2026$233M$1.2B$0.4731.07%-$475M
Q2 FY2026$164M-$1.2B-$3.32-43.93%-$584M
Q1 FY2026$115M-$347M-$1.06-20.6%-$139M
Q4 FY2025$80M$214M$0.6716.3%-$122M
Q3 FY2025$81M-$147M-$0.45-80.7%-$123M

Recent fiscal years

PeriodRevenueNet IncomeEPSOperating MarginFree Cash Flow
FY2025$319M-$289M-$0.88-70.39%-$451M
FY2024$511M-$1.3B-$4.87-3.76%-$52M
FY2023$502M-$246M-$0.651.78%$49M

Frequently asked questions

What was Core Scientific Inc.'s revenue last quarter?

Core Scientific Inc. reported revenue of $232.9 million for Q3 FY2026, up 187.1% from the same period a year earlier.

Is Core Scientific Inc. profitable?

Yes. Core Scientific Inc. reported net income of $1.18 billion for Q3 FY2026, a net margin of 505.93% on revenue.

How has Core Scientific Inc.'s margin trended?

Operating margin was 31.07% in Q3 FY2026, compared with -80.7% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.

How much free cash flow did Core Scientific Inc. generate?

Core Scientific Inc. generated free cash flow of -$475.4 million in Q3 FY2026, after capital expenditure.

Full income statement, balance sheet and cash flow for Core Scientific, Inc. Common Stock on SentiSense, with up to forty quarters and twenty fiscal years of history.